NEAC will continue to be your resource for superior NCLEX information and application preparations.  Simply contact your Processing Officer for additional questions and come by our office to get started your NCLEX Eligibility Application or if you need assistance with any other aspect of becoming a U.S.RN. Below you can find NCLEX and U.S. Licensing related news that may effect international applicants.

MISSISSIPPI (July 2010): Now requires SSN in order to Apply ARIZONA (February 2010): Requires proof of Citizenship or Legal Residency in order to Apply CALIFORNIA (April 2010): Now requires SSN in order to Apply MISSOURI (June 2010): Joins Compact States VERMONT (2009): Requires CES SOME STATES: Changes CGFNS-CP Requirement to CES NEW MEXICO (February 2008): Requires CES CALIFORNIA (March 2008): California Requires Local License

Announcement from Legal Counsel at the Department of Consumer Affairs
for the State of California

15 July 2010

Acording to a decision by the Legal Counsel at the Department of Consumer Affairs for the State of California, any application not yet found eligible by April 26th must be rejected and returned to the applicants. 

--------------------------------------------------------------------------------------------------------------------------------------------------------

ATTENTION: CABON Now Requires SSN to apply for NCLEX.

For those applicants who have failed the exam and want to re-apply; CABON will not accept re-application without U.S Social Security Number.

Visit NEAC Centers to avail free NCLEX Eligibility Application Consultation, initial requirements and fees.

--------------------------------------------------------------------------------------------------------------------------------------------------------

Philippines Testing Site OPENS!

CHICAGO - The National Council of State Boards of Nursing, Inc. (NCSBN) began NCLEX testing in Manila, the capital city of the Philippines, at the international Pearson Professional Center on Aug. 23, 2007.

The Manila site was chosen in February by the NCSBN Board of Directors because of the deep commitment shown by the Philippine government to ensuring a secure test center. The placement of a test site in the Philippines will allow for greater customer service to nurses without compromising the goal of safeguarding the public health, safety and welfare of patients in the U.S. Intended for the purposes of domestic nurse licensure in U.S. states and territories, all security policies and procedures currently used to administer the NCLEX examination domestically will be fully implemented at this new site. Administration of the NCLEX examination abroad does not contradict or circumvent any current board of nursing process or requirement. All international candidates are required to apply to the board of nursing in the state or territory where they wish to be licensed before registering for the NCLEX examination.

The NCLEX examination fee for all candidates is $200. Candidates who elect to take the NCLEX at an international site pay an additional $150 when they schedule their examination. State and territorial NCLEX examination fees remain at their current levels and are not being used to subsidize the international testing initiative. Offered abroad since January 2005, the current international sites for NCLEX examinations are in London, England; Hong Kong; Sydney, Australia; Toronto, Montreal, and Vancouver, Canada; Frankfurt, Germany; Mumbai, New Delhi, Hyderabad, Bangalore, and Chennai, India; Mexico City, Mexico; Taipei, Taiwan; and Chiyoda-ku and Yokohama, Japan. The National Council of State Boards of Nursing, Inc. (NCSBN) is a not-for-profit organization whose membership comprises the boards of nursing in the 50 states, the District of Columbia and four U.S. territories.

--------------------------------------------------------------------------------------------------------------------------------------------------------

NCSBN Selects the Philippines as International Testing Site for NCLEX® Examinations

NCSBN has selected Manila, the capital city of the Philippines, as a new site for the administration of the NCLEX® examinations.

CHICAGO – The National Council of State Boards of Nursing (NCSBN®) has selected Manila, the capital city of the Philippines, as a new site for the administration of the NCLEX® examinations. NCSBN's Board of Directors made the decision to expand the number of sites at its Feb. 8, 2007, meeting.

Faith Fields, MSN, RN, president, NCSBN Board of Directors, comments, “The Philippine government has shown a deep commitment to ensuring a secure test center in Manila and has been very responsive to NCSBN concerns. Placing a test site in the Philippines will allow for greater customer service to nurses without compromising the goal of safeguarding the public health, safety and welfare of patients in the U.S.”

Offered abroad since January 2005, the current international sites for NCLEX examinations are in London, England; Seoul, South Korea; Hong Kong; Sydney, Australia; Toronto, Montreal, and Vancouver, Canada; Frankfurt, Germany; Mumbai, New Delhi, Hyderabad, Bangalore, and Chennai, India; Mexico City, Mexico; Taipei, Taiwan; and Chiyoda-ku and Yokohama, Japan.

Intended for the purposes of domestic nurse licensure in U.S. states and territories, all security policies and procedures currently used to administer the NCLEX examination domestically will be fully implemented at this new site. At this time, no schedule of implementation has been set.

The National Council of State Boards of Nursing, Inc. (NCSBN) is a not-for-profit organization whose membership comprises the boards of nursing in the 50 states, the District of Columbia and four U.S. territories.
Mission: The National Council of State Boards of Nursing (NCSBN), composed of Member Boards, provides leadership to advance regulatory excellence for public protection.

25,000 to 50,000 Filipino nurses are expected to take the first NCLEX tests in Manila, where the examinees stand to save a large part of what they could be spending if they were to take the test abroad.